Recent advances, and unresolved issues, in the application of computational modelling to the prediction of the biological effects of nanomaterials

Toxicology and Applied Pharmacology

Volumn 299, Issue , 2016, Pages 96-100

  Winkler, David A ^a,b,c,d  

^a CSIRO   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

^d FLINDERS UNIVERSITY   (Australia)

Author keywords

Computational modelling; Molecular dynamics; Nanotoxicology; Quantitative structure property relationship, QSPR; Recent advances; Unresolved issues

Indexed keywords

NANOPARTICLE; BIOMATERIAL; NANOMATERIAL;

AB INITIO CALCULATION; ARTICLE; BIOLOGICAL ACTIVITY; ENVIRONMENT; HUMAN; MACHINE LEARNING; NONHUMAN; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL MODEL; ANIMAL; CELL MEMBRANE; CHEMISTRY; COMPUTER SIMULATION; DRUG EFFECTS; FORECASTING; METABOLISM; TRENDS;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL MEMBRANE; COMPUTER SIMULATION; FORECASTING; HUMANS; NANOSTRUCTURES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84952890248     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2015.12.016     Document Type: Article

References (89)

1. 2: correct statistical usage in QSAR and QSPR studies. J. Chem. Inf. Model. 2015, 55:1316-1322.
2. Arora S., Rajwade J.M., Paknikar K.M. Nanotoxicology and in vitro studies: the need of the hour. Toxicol. Appl. Pharmacol. 2012, 258:151-165.
3. Barnard A.S. How can ab initio simulations address risks in nanotech?. Nat. Nanotech. 2009, 4:332-335.
4. Barnard A.S. Modelling of nanoparticles: approaches to morphology and evolution. Rep. Prog. Phys. 2010, 73.
5. Barnard A.S. Clarifying stability, probability and population in nanoparticle ensembles. Nanoscale 2014, 6:9983-9990.
6. Barnard A.S. In silico veritas. ACS Nano 2014, 8:6520-6525.
7. Barnard A.S., Snook I.K. Ideality versus reality: predicting the effect of realistic environments on the electronic properties of nanographene. Nanosci. Nanotech. Lett. 2011, 3:59-62.
8. Barnard A.S., Snook I.K. Modelling the role of size, edge structure and terminations on the electronic properties of graphene nano-flakes. Mod. Simul. Mat. Sci. 2011, 19:1-12.
9. bcc Research Nanotechnology: a realistic market assessment. BCC Research 2014, report code NAN031F.
10. Beddoes C.M., Case C.P., Briscoe W.H. Understanding nanoparticle cellular entry: a physicochemical perspective. Adv. Colloid Interf. Sci. 2015, 218:48-68.
11. Bhunia A.K., Samanta P.K., Saha S., Kamilya T. ZnO nanoparticle-protein interaction: corona formation with associated unfolding. Appl. Phys. Lett. 2013, 103:143701.
12. Bigdeli A., Hormozi-Nezhad M.R., Jalali-Heravi M., Abedini M.R., Sharif-Bakhtiar F. Towards defining new nano-descriptors: extracting morphological features from transmission electron microscopy images. RSC Adv. 2014, 4:60135-60143.
13. Bigdeli A., Hormozi-Nezhad M.R., Parastar H. Using nano-QSAR to determine the most responsible factor(s) in gold nanoparticle exocytosis. RSC Adv. 2015, 5:57030-57037.
14. Borders T.L., Fonseca A.F., Zhang H., Cho K., Rusinko A. Developing descriptors to predict mechanical properties of nanotubes. J. Chem. Inf. Model. 2013, 53:773-782.
15. Chaudhury K., Kumar V., Kandasamy J., RoyChoudhury S. Regenerative nanomedicine: current perspectives and future directions. Int. J. Nanomed. 2014, 9:4153-4167.
16. Chen P.Y., Seabrook S.A., Epa V.C., Kurabayashi K., Barnard A.S., Winkler D.A., Kirby J.K., Ke P.C. Contrasting effects of nanoparticle binding on protein denaturation. J. Phys. Chem. C 2014, 118:22069-22078.
17. Cherkasov A., Muratov E.N., Fourches D., Varnek A., Baskin I.I., Cronin M., Dearden J., Gramatica P., Martin Y.C., Todeschini R., Consonni V., Kuz'min V.E., Cramer R., Benigni R., Yang C., Rathman J., Terfloth L., Gasteiger J., Richard A., Tropsha A. QSAR modeling: where have you been? Where are you going to?. J. Med. Chem. 2014, 57:4977-5010.
18. Cristea P.D., Tuduce R., Arsene O., Dinca A., Fulga F., Nicolau D.V. Modeling of biological nanostructured surfaces. Nanoscale Image. Sens. Actuat. Biomed. Appl. 2010, 7574.
19. De Leo F., Sgrignani J., Bonifazi D., Magistrato A. Structural and dynamic properties of monoclonal antibodies immobilized on CNTs: a computational study. Chem. Eur. J. 2013, 19:12281-12293.
20. Ding H.-m., Ma Y.-q. Theoretical and computational investigations of nanoparticle-biomembrane interactions in cellular delivery. Small 2015, 11:1055-1071.
21. Dobay M.P.D., Alberola A.P., Mendoza E.R., Raedler J.O. Modeling nanoparticle uptake and intracellular distribution using stochastic process algebras. J. Nanopart. Res. 2012, 14.
22. Docter D., Strieth S., Westmeier D., Hayden O., Gao M., Knauer S.K., Stauber R.H. No king without a crown - impact of the nanomaterial-protein corona on nanobiomedicine. Nanomed. 2015, 10:503-519.
23. Docter D., Westmeier D., Markiewicz M., Stolte S., Knauer S.K., Stauber R.H. The nanoparticle biomolecule corona: lessons learned - challenge accepted?. Chem. Soc. Rev. 2015, 44:6094-6121.
24. Epa V.C., Burden F.R., Tassa C., Weissleder R., Shaw S., Winkler D.A. Modeling biological activities of nanoparticles. Nano Lett. 2012, 12:5808-5812.
25. Epa V.C., Winkler D.A., Tran L., Fadeel B., Pietroiusti A., Shvedova A. Computational approaches. Adverse Effects of Engineered Nanomaterials: Exposure, Toxicology, and Impact on Human Health 2012, 85-96. Academic Press, London. B. Fadeel, A. Pietroiusti, A.A. Shvedova (Eds.).
26. Farcal L., Andon F.T., Di Cristo L., Rotoli B.M., Bussolati O., Bergamaschi E., Mech A., Hartmann N.B., Rasmussen K., Riego-Sintes J., Ponti J., Kinsner-Ovaskainen A., Rossi F., Oomen A., Bos P., Chen R., Bai R., Chen C., Rocks L., Fulton N., Ross B., Hutchison G., Tran L., Mues S., Ossig R., Schnekenburger J., Campagnolo L., Vecchione L., Pietroiusti A., Fadeel B. Comprehensive in vitro toxicity testing of a panel of representative oxide nanomaterials: first steps towards an intelligent testing strategy. PLoS One 2015, 10.
27. Feigl C., Russo S.P., Barnard A.S. Safe, stable and effective nanotechnology: phase mapping of ZnS nanoparticles. J. Mater. Chem. 2010, 20:4971-4980.
28. Forloni G. Responsible nanotechnology development. J. Nanopart. Res. 2012, 14:1007.
29. Fourches D., Pu D., Tropsha A. Exploring quantitative nanostructure-activity relationships (QNAR) modeling as a tool for predicting biological effects of manufactured nanoparticles. Comb. Chem. High Throughput Screen. 2011, 14:217-225.
30. Fourches D., Pu D., Tropsha A. Quantitative nanostructure-activity relationships (QNAR) models as a tool for predicting biological effects of manufactured nanoparticles. Abstr. Pap. Am. Chem. Soc. 2011, 241.
31. Gajewicz A., Cronin M.T.D., Rasulev B., Leszczynski J., Puzyn T. Novel approach for efficient predictions properties of large pool of nanomaterials based on limited set of species: nano-read-across. Nanotech. 2015, 26.
32. Gajewicz A., Schaeublin N., Rasulev B., Hussain S., Leszczynska D., Puzyn T., Leszczynski J. Towards understanding mechanisms governing cytotoxicity of metal oxides nanoparticles: hints from nano-QSAR studies. Nanotoxicol. 2015, 9:313-325.
33. Ghorbanzadeh M., Fatemi M.H., Karimpour M. Modeling the cellular uptake of magnetofluorescent nanoparticles in pancreatic cancer cells: a quantitative structure activity relationship study. Ind. Eng. Chem. Res. 2012, 51:10712-10718.
34. Goldberg E., Scheringer M., Bucheli T.D., Hungerbuehler K. Prediction of nanoparticle transport behavior from physicochemical properties: machine learning provides insights to guide the next generation of transport models. Environ. Sci. Nano 2015, 2:352-360.
35. Guo H.B., Barnard A.S. Modeling the iron oxides and oxyhydroxides for the prediction of environmentally sensitive phase transformations. Phys. Rev. B 2011, 83.
36. Guo H.B., Barnard A.S. Thermodynamic modelling of nanomorphologies of hematite and goethite. J. Mater. Chem. 2011, 21:11566-11577.
37. Guo H.B., Barnard A.S. Naturally occurring iron oxide nanoparticles: morphology, surface chemistry and environmental stability. J. Mater. Chem. A. 2013, 1:27-42.
38. Hastings J., Jeliazkova N., Owen G., Tsiliki G., Munteanu C.R., Steinbeck C., Willighagen E. eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment. J. Biomed. Semant. 2015, 6:10.
39. Kamath P., Fernandez A., Giralt F., Rallo R. Predicting cell association of surface-modified nanoparticles using protein corona structure-activity relationships (PCSAR). Curr. Top. Med. Chem. 2015, 15:1930-1937.
40. Kar S., Gajewicz A., Puzyn T., Roy K. Nano-quantitative structure-activity relationship modeling using easily computable and interpretable descriptors for uptake of magnetofluorescent engineered nanoparticles in pancreatic cancer cells. Toxicol. in Vitro 2014, 28:600-606.
41. Kar S., Gajewicz A., Puzyn T., Roy K., Leszczynski J. Periodic table-based descriptors to encode cytotoxicity profile of metal oxide nanoparticles: a mechanistic QSTR approach. Ecotoxicol. Environ. Saf. 2014, 107:162-169.
42. Kaweeteerawat C., Ivask A., Liu R., Zhang H., Chang C.H., Low-Kam C., Fischer H., Ji Z., Pokhrel S., Cohen Y., Telesca D., Zink J., Maedler L., Holden P.A., Nel A., Godwin H. Toxicity of metal oxide nanoparticles in Escherichia coli correlates with conduction band and hydration energies. Environ. Sci. Technol. 2015, 49:1105-1112.
43. Kleandrova V.V., Luan F., Gonzalez-Diaz H., Ruso J.M., Melo A., Speck-Planche A., Cordeiro M.N.D.S. Computational ecotoxicology: simultaneous prediction of ecotoxic effects of nanoparticles under different experimental conditions. Environ. Int. 2014, 73:288-294.
44. Kleandrova V.V., Luan F., Gonzalez-Diaz H., Ruso J.M., Speck-Planche A., Cordeiro M.N.D.S. Computational tool for risk assessment of nanomaterials: novel QSTR-perturbation model for simultaneous prediction of ecotoxicity and cytotoxicity of uncoated and coated nanoparticles under multiple experimental conditions. Environ. Sci. Technol. 2014, 48:14686-14694.
45. Kumar A., Kumar P., Anandan A., Fernandes T.F., Ayoko G.A., Biskos G. Engineered nanomaterials: knowledge gaps in fate, exposure, toxicity, and future directions. J. Nanomat. 2014, Article ID 130198.
46. Kumar P., Khan R.A., Choonara Y.E., Pillay V. A prospective overview of the essential requirements in molecular modeling for nanomedicine design. Future. Med. Chem. 2013, 5:929-946.
47. Le T., Epa V.C., Burden F.R., Winkler D.A. Quantitative structure-property relationship modeling of diverse materials properties. Chem. Rev. 2012, 112:2889-2919.
48. Lee S., Park K., Ahn H.S., Kim D. Importance of structural information in predicting human acute toxicity from in vitro cytotoxicity data. Toxicol. Appl. Pharmacol. 2010, 246:38-48.
49. Lehner R., Wang X., Marsch S., Hunziker P. Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application. Nanomed. Nanotechnol. Biol. Med. 2013, 9:742-757.
50. Liu R., Jiang W., Walkey C.D., Chan W.C.W., Cohen Y. Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties. Nanoscale 2015, 7:9664-9675.
51. Liu Y., Winkler D.A., Epa V.C., Zhang B., Yan B. Probing enzyme-nanoparticle interactions using combinatorial gold nanoparticle libraries. Nano Res. 2015, 8:1293-1308.
52. Mahmoudi M., Lynch I., Ejtehadi M.R., Monopoli M.P., Bombelli F.B., Laurent S. Protein-nanoparticle interactions: opportunities and challenges. Chem. Rev. 2011, 111:5610-5637.
53. Makarucha A.J., Todorova N., Yarovsky I. Nanomaterials in biological environment: a review of computer modelling studies. Eur. Biophys. J. 2011, 40:103-115.
54. Maojo V., Fritts M., de la Iglesia D., Cachau R.E., Garcia-Remesal M., Mitchell J.A., Kulikowski C. Nanoinformatics: a new area of research in nanomedicine. Int. J. Nanomedicine 2012, 7:3867-3890.
55. Marvin H.J.P., Bouwmeester H., Bakker M., Kroese E.D., van de Meent D., Bourgeois F., Lokers R., van der Ham H., Verhelst L. Exploring the development of a decision support system (DSS) to prioritize engineered nanoparticles for risk assessment. J. Nanoparticle Res. 2013, 15:1839.
56. Melagraki G., Afantitis A. Enalos InSilicoNano platform: an online decision support tool for the design and virtual screening of nanoparticles. RSC Adv. 2014, 4:50713-50725.
57. Melagraki G., Afantitis A. A risk assessment tool for the virtual screening of metal oxide nanoparticles through enalos InSilicoNano platform. Curr. Top. Med. Chem. 2015, 15:1827-1836.
58. Monopoli M.P., Aberg C., Salvati A., Dawson K.A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 2012, 7:779-786.
59. Mu Q., Jiang G., Chen L., Zhou H., Fourches D., Tropsha A., Yan B. Chemical basis of interactions between engineered nanoparticles and biological systems. Chem. Rev. 2014, 114:7740-7781.
60. Editorial N.N. The dose makes the poison. Nat. Nanotechnol. 2011, 6:329-329.
61. Oksel C., Ma C.Y., Liu J.J., Wilkins T., Wang X.Z. (Q)SAR modelling of nanomaterial toxicity: a critical review. Particuol. 2015, 21:1-19.
62. Oksel C., Ma C.Y., Wang X.Z. Current situation on the availability of nanostructure-biological activity data. SAR QSAR Environ. Res. 2015, 26:79-94.
63. Panneerselvam S., Choi S. Nanoinformatics: emerging databases and available tools. Int. J. Mol. Sci. 2014, 15:7158-7182.
64. Pathakoti K., Huang M.-J., Watts J.D., He X., Hwang H.-M. Using experimental data of Escherichia coli to develop a QSAR model for predicting the photo-induced cytotoxicity of metal oxide nanoparticles. J. Photochem. Photobiol. B 2014, 130:234-240.
65. Puzyn T., Rasulev B., Gajewicz A., Hu X.K., Dasari T.P., Michalkova A., Hwang H.M., Toropov A., Leszczynska D., Leszczynski J. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat. Nanotechnol. 2011, 6:175-178.
66. Qu Z.G., He X.C., Lin M., Sha B.Y., Shi X.H., Lu T.J., Xu F. Advances in the understanding of nanomaterial-biomembrane interactions and their mathematical and numerical modeling. Nanomed. 2013, 8:995-1011.
67. Rihn B.H., Joubere O. Comment on "protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles". ACS Nano 2015, 9:5634-5635.
68. Salahinejad M. Nano-QSPR modelling of carbon-based nanomaterials properties. Curr. Top. Med. Chem. 2015, 15:1868-1886.
69. Shi H.Q., Barnard A.S., Snook I.K. High throughput theory and simulation of nanomaterials: exploring the stability and electronic properties of nanographene. J. Mater. Chem. 2012, 22:18119-18123.
70. Tavanti F., Pedone A., Menziani M.C. A closer look into the ubiquitin corona on gold nanoparticles by computational studies. New J. Chem. 2015, 39:2474-2482.
71. Tavanti F., Pedone A., Menziani M.C. Competitive binding of proteins to gold nanoparticles disclosed by molecular dynamics simulations. J. Phys. Chem. C ASAP 2015, 119(38):22172-22180.
72. Teli M.K., Mutalik S., Rajanikant G.K. Nanotechnology and nanomedicine: going small means aiming big. Curr. Pharm. Des. 2010, 16:1882-1892.
73. Teske S.S., Detweiler C.S. The biomechanisms of metal and metal-oxide nanoparticles' interactions with cells. Int. J. Environ. Res. 2015, 12:1112-1134.
74. Todorova N., Makarucha A.J., Hine N.D.M., Mostofi A.A., Yarovsky I. Dimensionality of carbon nanomaterials determines the binding and dynamics of amyloidogenic peptides: multiscale theoretical simulations. PLoS Comput. Biol. 2013, 9.
75. Toropov A.A., Rallo R., Toropova A.P. Use of quasi-SMILES and Monte Carlo optimization to develop quantitative feature property/activity relationships (QFPR/QFAR) for nanomaterials. Curr. Top. Med. Chem. 2015, 15:1837-1844.
76. Toropov A.A., Toropova A.P. Quasi-QSAR for mutagenic potential of multi-walled carbon-nanotubes. Chemosphere 2015, 124:40-46.
77. Toropov A.A., Toropova A.P., Veselinovic A.M., Veselinovic J.B., Nesmerak K., Raska I., Duchowicz P.R., Castro E.A., Kudyshkin V.O., Leszczynska D., Leszczynski J. The Monte Carlo method based on eclectic data as an efficient tool for predictions of endpoints for nanomaterials - two examples of application. Comb. Chem. High Throughput Screen. 2015, 18:376-386.
78. Toropova A.P., Toropov A.A. Mutagenicity: QSAR - quasi-QSAR-nano-QSAR. Mini-Rev. Med. Chem. 2015, 15:608-621.
79. 2 nanoparticles on human lung fibroblasts. J. Nanopart. Res. 2014, 16:2282.
80. Toropova A.P., Toropov A.A., Benfenati E., Korenstein R., Leszczynska D., Leszczynski J. Optimal nano-descriptors as translators of eclectic data into prediction of the cell membrane damage by means of nano metal-oxides. Environ. Sci. Pollut. Res. 2015, 22:745-757.
81. 2 nanoparticles. Ecotoxicol. Environ. Saf. 2014, 108:203-209.
82. Vance M.E., Kuiken T., Vejerano E.P., McGinnis S.P., Hochella M.F., Rejeski D., Hull M.S. Nanotechnology in the real world: redeveloping the nanomaterial consumer products inventory. Beilstein J. Nanotech. 2015, 6:1769-1780.
83. Walkey C.D., Olsen J.B., Song F., Liu R., Guo H., Olsen D.W.H., Cohen Y., Emili A., Chan W.C.W. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 2014, 8:2439-2455.
84. Wang B., Seabrook S.A., Nedumpully-Govindan P., Chen P., Yin H., Waddington L., Epa V.C., Winkler D.A., Kirby J.K., Ding F., Ke P.C. Thermostability and reversibility of silver nanoparticle-protein binding. Phys. Chem. Chem. Phys. 2015, 17:1728-1739.
85. Winkler D.A., Burden F.R., Yan B., Weissleder R., Tassa C., Shaw S., Epa V.C. Modelling and predicting the biological effects of nanomaterials. SAR QSAR Environ. Res. 2014, 25:161-172.
86. Winkler D.A., Mombelli E., Pietroiusti A., Tran L., Worth A., Fadeel B., McCall M.J. Applying quantitative structure-activity relationship approaches to nanotoxicology: current status and future potential. Toxicol. 2013, 313:15-23.
87. Xiao L., Tang K., Liu X., Yang H., Chen Z., Xu R. Information extraction from nanotoxicity related publications. 2013 Ieee International Conference on Bioinformatics and Biomedicine 2013, pp. G.Z. Li, S. Kim, M. Hughes, G. McLachlan, H. Sun, X. Hu, H. Ressom, B. Liu, M. Liebman (Eds.).
88. Zhang W. Nanoparticle aggregation: principles and modeling. Nanomaterial: Impacts on Cell Biology and Medicine 2014, 19-43. D.G. Capco, Y. Chen (Eds.).
89. Zhang X.-Q., Xu X., Bertrand N., Pridgen E., Swami A., Farokhzad O.C. Interactions of nanomaterials and biological systems: implications to personalized nanomedicine. Adv. Drug Deliv. Rev. 2012, 64:1363-1384.